Private capital asset manager Pollen Street has agreed to acquire Finastra’s global core banking software business, Universal Banking (UB), according to a June 19, 2025, press release. The transaction, pending regulatory approvals, will see UB operate as an independent entity led by its existing management team, with Pollen Street providing capital to accelerate product innovation and expand capabilities, the companies stated.
What is Universal Banking?
Universal Banking’s cloud-first, open banking platform, Essence, supports over 150 financial institutions across 100+ countries, including digital banks, Islamic banks, and building societies. The software enables institutions to modernize legacy systems, with Pollen Street’s investment targeting generative AI and data capabilities, according to the release.
Why is this acquisition significant?
Finastra CEO Chris Walters emphasized that the deal allows the company to “sharpen focus on payments and lending,” areas he described as “significant opportunities to grow.” The sale follows Finastra’s May 2025 divestiture of its treasury and capital management business and a June 4 announcement to sell its U.S. mid-market banking division, signaling a strategic pivot.
What’s next for Finastra?
Walters, who joined Finastra as CEO in January 2025 after roles at Avantax, stated the UB transaction “enables greater value for customers.” Finastra’s ongoing restructuring includes exiting non-core segments, a move aligning with broader industry trends of specialization in high-growth areas like payments.
How does Pollen Street’s investment plan look?
Pollen Street, which manages over €8 billion in assets, plans to support UB’s growth through AI-led innovation. Partner Anastasia Kovaleva highlighted the business’s “strong foundation” and potential for expansion, noting the platform’s role in helping clients “accelerate modernization journeys.”
The deal underscores the increasing consolidation in fintech, with private capital playing a key role in scaling specialized software solutions. Regulatory approvals remain the next critical step before the transaction closes.
